Contents

Current Cancer Drug Targets, Volume 9 - Number 8

Cytokines in the Management of High Risk or Advanced Breast Cancer: An Update and Expectation

, 9(8): 888 - 903

A. Carpi, A. Nicolini, A. Antonelli, P. Ferrari and G. Rossi


DOI: 10.2174/156800909790192392




Voltage-Dependent Potassium Channels Kv1.3 and Kv1.5 in Human Cancer

, 9(8): 904 - 914

J. Bielanska, J. Hernandez-Losa, M. Perez-Verdaguer, T. Moline, R. Somoza, S. Ramon y Cajal, E. Condom, J. C. Ferreres and A. Felipe


DOI: 10.2174/156800909790192400




Gadd45 Proteins as Critical Signal Transducers Linking NF-κB to MAPK Cascades

, 9(8): 915 - 930

Z. Yang, L. Song and C. Huang


DOI: 10.2174/156800909790192383




Dual EGFR and COX-2 Inhibition as a Novel Approach to Targeting Head and Neck Squamous Cell Carcinoma

, 9(8): 931 - 937

J. Kao, A. T. Sikora and S. Fu


DOI: 10.2174/156800909790192437




Indoleamine 2,3-Dioxygenase, an Emerging Target for Anti-Cancer Therapy

, 9(8): 938 - 952

X. Liu, R. C. Newton, S. M. Friedman and P. A. Scherle


DOI: 10.2174/156800909790192374




Poly(ADP-ribose) Glycohydrolase Deficiency Sensitizes Mouse ES Cells to DNA Damaging Agents

, 9(8): 953 - 962

H. Fujihara, H. Ogino, D. Maeda, H. Shirai, T. Nozaki, N. Kamada, K. Jishage, S. Tanuma, T. Takato, T. Ochiya, T. Sugimura and M. Masutani


DOI: 10.2174/156800909790192419




Epigenetic Therapy: Histone Acetylation, DNA Methylation and Anti-Cancer Drug Discovery

, 9(8): 963 - 981

A. Ganesan, L. Nolan, S. J. Crabb and G. Packham


DOI: 10.2174/156800909790192428




Antibody-Drug Conjugate Targets

, 9(8): 982 - 1004

B. A. Teicher


DOI: 10.2174/156800909790192365




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science